Fluticasone furoate, vilanterol 50/25mcg, 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Fluticasone furoate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity.

In the combination with Fluticasone Furoate + Vilanterol (Trial 4 [NCT #01957163] and Trial 5 [NCT #02119286]): Patients were randomly assigned to Incruse Ellipta 62.5 mcg + FF/VI 100 mcg/25 mcg ...

The announcement comes months after GSK’s struggling respiratory division suffered a setback, when the large-scale SUMMIT trial failed to show its Relvar Ellipta (fluticasone furoate+vilanterol ...

and ensifentrine's top-line exacerbation reduction rate of 40% compares favourably with established therapies like GSK's Breo (fluticasone furoate/vilanterol) and Trelegy (fluticasone furoate ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...